Anthony S. Fiorino Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Anthony S. Fiorino.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anthony S. Fiorino. Anthony S. Fiorino is Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and Chief Executive Officer in BRAINSTORM CELL THERAPEUTICS INC. ($BCLI) and Chief Medical Officer and COO in IMMUNE PHARMACEUTICALS INC ($IMNP) and Director in IMMUNE PHARMACEUTICALS INC ($IMNP).
Latest Insider Trading Transactions of Anthony S. Fiorino
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCLI, IMNP, NAVB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 04 2020 | IMNP | IMMUNE PHARMACEUTI ... | Fiorino Anthony S. | Director | Sell | S | 0.00 | 75,000 | 263 | 0 | 75 K to 0 (-100.00 %) |
| May 23 2018 | IMNP | IMMUNE PHARMACEUTI ... | Fiorino Anthony S. | Chief Medical Offic ... | Buy | P | 0.24 | 25,000 | 5,978 | 75,000 | 50 K to 75 K (+50.00 %) |
| May 18 2018 | IMNP | IMMUNE PHARMACEUTI ... | Fiorino Anthony S. | Chief Medical Offic ... | Buy | P | 0.26 | 50,000 | 12,900 | 50,000 | 0 to 50 K |
| Sep 18 2017 | IMNP | IMMUNE PHARMACEUTI ... | Fiorino Anthony S. | Chief Medical Offic ... | Option Exercise | A | 1.10 | 90,000 | 99,000 | 90,000 | |
| Jun 30 2017 | NAVB | NAVIDEA BIOPHARMAC ... | Fiorino Anthony S. | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 50,000 | |
| Jun 30 2017 | NAVB | NAVIDEA BIOPHARMAC ... | Fiorino Anthony S. | Director | Grant | A | 0.00 | 50,000 | 50 | 78,000 | 28 K to 78 K (+178.57 %) |
| Apr 29 2016 | NAVB | NAVIDEA BIOPHARMAC ... | Fiorino Anthony S. | Director | Grant | A | 0.00 | 28,000 | 0 | 28,000 | 0 to 28 K |
| Sep 16 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Buy | P | 0.28 | 3,000 | 851 | 18,000 | 15 K to 18 K (+20.00 %) |
| Sep 16 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Buy | P | 0.29 | 5,000 | 1,438 | 15,000 | 10 K to 15 K (+50.00 %) |
| Sep 16 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Buy | P | 0.29 | 7,500 | 2,138 | 10,000 | 2.5 K to 10 K (+300.00 %) |
| Sep 16 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Buy | P | 0.28 | 2,500 | 700 | 2,500 | 0 to 2.5 K |
| Jun 10 2014 | BCLI | BRAINSTORM CELL TH ... | Fiorino Anthony S. | Chief Executive Off ... | Option Exercise | A | 0.30 | 5,700,000 | 1,710,000 | 5,700,000 |
Page: 1